Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Research ArticleArticle

Phase II Conjugates of Urolithins Isolated from Human Urine and Potential Role of β-Glucuronidases in Their Disposition

Jakub P. Piwowarski, Iwona Stanisławska, Sebastian Granica, Joanna Stefańska and Anna K. Kiss
Drug Metabolism and Disposition June 2017, 45 (6) 657-665; DOI: https://doi.org/10.1124/dmd.117.075200
Jakub P. Piwowarski
Department of Pharmacognosy and Molecular Basis of Phytotherapy, Faculty of Pharmacy (J.P.P., I.S., S.G., A.K.K.), and Department of Pharmaceutical Microbiology, Centre for Preclinical Research and Technology (CePT) (J.S.), Medical University of Warsaw, Warsaw, Poland; Primary Laboratory of Origin: Medical University of Warsaw, Faculty of Pharmacy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Iwona Stanisławska
Department of Pharmacognosy and Molecular Basis of Phytotherapy, Faculty of Pharmacy (J.P.P., I.S., S.G., A.K.K.), and Department of Pharmaceutical Microbiology, Centre for Preclinical Research and Technology (CePT) (J.S.), Medical University of Warsaw, Warsaw, Poland; Primary Laboratory of Origin: Medical University of Warsaw, Faculty of Pharmacy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sebastian Granica
Department of Pharmacognosy and Molecular Basis of Phytotherapy, Faculty of Pharmacy (J.P.P., I.S., S.G., A.K.K.), and Department of Pharmaceutical Microbiology, Centre for Preclinical Research and Technology (CePT) (J.S.), Medical University of Warsaw, Warsaw, Poland; Primary Laboratory of Origin: Medical University of Warsaw, Faculty of Pharmacy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joanna Stefańska
Department of Pharmacognosy and Molecular Basis of Phytotherapy, Faculty of Pharmacy (J.P.P., I.S., S.G., A.K.K.), and Department of Pharmaceutical Microbiology, Centre for Preclinical Research and Technology (CePT) (J.S.), Medical University of Warsaw, Warsaw, Poland; Primary Laboratory of Origin: Medical University of Warsaw, Faculty of Pharmacy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anna K. Kiss
Department of Pharmacognosy and Molecular Basis of Phytotherapy, Faculty of Pharmacy (J.P.P., I.S., S.G., A.K.K.), and Department of Pharmaceutical Microbiology, Centre for Preclinical Research and Technology (CePT) (J.S.), Medical University of Warsaw, Warsaw, Poland; Primary Laboratory of Origin: Medical University of Warsaw, Faculty of Pharmacy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 45 no. 6 657-665
DOI 
https://doi.org/10.1124/dmd.117.075200
PubMed 
28283501

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received January 24, 2017
  • Accepted March 1, 2017
  • Published online May 4, 2017.

Article Versions

  • Earlier version (March 10, 2017 - 08:43).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Jakub P. Piwowarski,
  2. Iwona Stanisławska,
  3. Sebastian Granica,
  4. Joanna Stefańska, and
  5. Anna K. Kiss
  1. Department of Pharmacognosy and Molecular Basis of Phytotherapy, Faculty of Pharmacy (J.P.P., I.S., S.G., A.K.K.), and Department of Pharmaceutical Microbiology, Centre for Preclinical Research and Technology (CePT) (J.S.), Medical University of Warsaw, Warsaw, Poland; Primary Laboratory of Origin: Medical University of Warsaw, Faculty of Pharmacy
  1. Address correspondence to:
    Dr. Jakub Piwowarski, Department of Pharmacognosy and Molecular Basis of Phytotherapy, Medical University of Warsaw, Faculty of Pharmacy, Banacha 1, 02-097 Warsaw, Poland. E-mail: jakub.piwowarski{at}wum.edu.pl
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: March 2017 to May 2022

AbstractFullPdf
Mar 201737313140
Apr 2017458081
May 20174004349
Jun 20171121520
Jul 20177614
Aug 201768919
Sep 20177288
Oct 201710367
Nov 2017150818
Dec 201787612
Jan 2018116521
Feb 201878514
Mar 201843218
Apr 201879417
May 201872951
Jun 201812735
Jul 201842227
Aug 201822720
Sep 201842422
Oct 201833230
Nov 201873328
Dec 201862630
Jan 201942621
Feb 201902821
Mar 201944936
Apr 2019123750
May 201965036
Jun 201913937
Jul 201936646
Aug 201912922
Sep 201952715
Oct 201916119
Nov 201943218
Dec 201993822
Jan 202025228
Feb 202043642
Mar 202023417
Apr 202042927
May 2020153849
Jun 20202179
Jul 202043537
Aug 202023031
Sep 2020103330
Oct 202033338
Nov 202053637
Dec 2020223641
Jan 2021104536
Feb 202173731
Mar 2021183263
Apr 2021323538
May 2021555647
Jun 202122416
Jul 202163846
Aug 202133529
Sep 202153233
Oct 202124741
Nov 202123236
Dec 202143319
Jan 202214236
Feb 202222625
Mar 202223721
Apr 202223423
May 202202922

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 45 (6)
Drug Metabolism and Disposition
Vol. 45, Issue 6
1 Jun 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Phase II Conjugates of Urolithins Isolated from Human Urine and Potential Role of β-Glucuronidases in Their Disposition
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Urolithin Conjugates, β-Glucuronidases, and Disposition

Jakub P. Piwowarski, Iwona Stanisławska, Sebastian Granica, Joanna Stefańska and Anna K. Kiss
Drug Metabolism and Disposition June 1, 2017, 45 (6) 657-665; DOI: https://doi.org/10.1124/dmd.117.075200

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Urolithin Conjugates, β-Glucuronidases, and Disposition

Jakub P. Piwowarski, Iwona Stanisławska, Sebastian Granica, Joanna Stefańska and Anna K. Kiss
Drug Metabolism and Disposition June 1, 2017, 45 (6) 657-665; DOI: https://doi.org/10.1124/dmd.117.075200
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Visual Overview
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Role of Human MSRA on Sulindac Activation
  • Determination of Acyl-, O-, and N-Glucuronide
  • TMDD Affects PK of IL-10 Fc-fusion Proteins
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics